formulation and evaluation of fast dissolving tablets atenolol
formulation and evaluation of fast dissolving tablets atenolol formulation and evaluation of fast dissolving tablets atenolol
www.jchps.comISSN: 0974-2115Journal of Chemical and Pharmaceutical SciencesTable-6.Cumulative percent drug released vs. time (zero order kinetics)TimeCumulative percentage Drug Release(min) B1 B2 B3 B4 B5 B6 B7 B8 B90 0 0 0 0 0 0 0 0 02 64.7 60.8 57.0 74.9 71.4 69.0 73.4 73.6 72.64 76.0 65.7 60.9 83.3 81.9 79.9 85.0 84.3 80.86 83.7 79.0 72.6 91.6 89.7 88.8 94.5 90.8 89.58 90.1 86.3 84.7 96.5 95.3 94.9 97.7 97.7 94.410 94.4 96.2 95.3 99.6 98.0 97.6 99.5 98.7 97.9Fig No. 3 IR Spectra of AtenololFig No. 4 IR Spectra of Atenolol + SSGApril – June 2013 117 JCPS Volume 6 Issue 2
- Page 6 and 7: www.jchps.comISSN: 0974-2115Journal
www.jchps.comISSN: 0974-2115Journal <strong>of</strong> Chemical <strong>and</strong> Pharmaceutical SciencesTable-6.Cumulative percent drug released vs. time (zero order kinetics)TimeCumulative percentage Drug Release(min) B1 B2 B3 B4 B5 B6 B7 B8 B90 0 0 0 0 0 0 0 0 02 64.7 60.8 57.0 74.9 71.4 69.0 73.4 73.6 72.64 76.0 65.7 60.9 83.3 81.9 79.9 85.0 84.3 80.86 83.7 79.0 72.6 91.6 89.7 88.8 94.5 90.8 89.58 90.1 86.3 84.7 96.5 95.3 94.9 97.7 97.7 94.410 94.4 96.2 95.3 99.6 98.0 97.6 99.5 98.7 97.9Fig No. 3 IR Spectra <strong>of</strong> AtenololFig No. 4 IR Spectra <strong>of</strong> Atenolol + SSGApril – June 2013 117 JCPS Volume 6 Issue 2
Change language